Identification of ferroptosis-related genes in pediatric Crohn's disease using bioinformatics approaches

Peng Lin1, Shuxia Xu2, Xiaoxiao Yan1

  • 1Department of Pathology, Fujian Children's Hospital (Fujian Branch of Shanghai Children's Medical Center), College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, 350000, China.

Scientific Reports
|October 30, 2025
PubMed

Insights

Ferroptosis plays a key role in pediatric Crohn's disease (PCD). This study identified key ferroptosis genes and immune cells, revealing IL1B as a promising diagnostic marker for PCD.

Area of Science:

  • Biomedical research
  • Genomics
  • Immunology

Background:

  • Ferroptosis is a critical mechanism in inflammatory bowel disease (IBD).
  • Understanding ferroptosis in pediatric Crohn's disease (PCD) is crucial for targeted therapies.

Purpose of the Study:

  • Identify key ferroptosis-related genes (FRGs) in PCD.
  • Analyze dysregulated signaling pathways and immune infiltration in PCD.
  • Evaluate diagnostic potential of identified genes.

Main Methods:

  • Integrated bioinformatics analysis of gene expression data (GSE117993).
  • Ferroptosis-related gene (FRG) curation from FerrDb.
  • Protein-protein interaction (PPI) network analysis.
  • Immune cell infiltration assessment (ssGSEA).
  • Receiver operating characteristic (ROC) curve analysis for validation.

Main Results:

  • Identified 1,074 differentially expressed genes (DEGs), including 21 FRGs-DEGs.
  • Enrichment analysis linked FRGs-DEGs to metabolic regulation and IL-17 signaling.
  • Five hub genes identified: PTGS2, IFNG, IL1B, IDO1, NOS2.
  • Significant accumulation of myeloid-derived suppressor cells (MDSCs) and neutrophils observed.
  • IL1B showed the highest diagnostic performance in validation cohorts.

Conclusions:

  • This study provides novel insights into ferroptosis mechanisms in PCD.
  • Identified hub genes, particularly IL1B, serve as potential diagnostic biomarkers.
  • Findings support advancing precision therapy for pediatric Crohn's disease.